The Linvatec arthroscopy unit of CONMED, a medical technology company, has achieved a milestone with significant advancement in biomaterials technology.
The company has launched the new GENESYS Matryx Interference screws using an innovative biocomposite material technology. With the use of a proprietary microfiltration process, CONMED Linvatec is able to fabricate one of the market’s smallest biocomposite interference screws currently available for fixing the posterior cruciate ligament (PCL) and anterior cruciate ligament (ACL) grafts.
The reconstruction of a failed ACL and PCL of the knee is often done using interference screw fixation. The implantation of the ligament and screw into the bone tunnel supports natural healing of the damaged ligament. The presence of Beta TriCalcium Phosphate, a bone pre-cursor, enables CONMED’s GENESYS Matryx Biocomposite Interference screw to support the bone formation. Thus, the product supports bone reconstruction and connection of the alternative ligament.
The new biocomposite screws are ideal for fixing soft tissues in PCL and ACL reconstructions. The smaller diameter screws facilitate reunion of the soft tissue to the bone. Thus, the screws are flexible to perform repairs in other parts of the body. CONMED Linvatec will continue to leverage its broader proficiency in biomaterials technology to provide a wide range of innovative solutions to its customers.
Source: http://www.conmed.com/